[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336549-105":59,"doc-detail-336549-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","surgically-resected-sarcomatoid-carcinoma-of-the-lung-a-nationwide-retrospective-study-in-2010","Surgically resected sarcomatoid carcinoma of the lung - a nationwide retrospective study in 2010","","Sarcomatoid carcinoma of the lung is a rare non-small cell lung cancer subtype with a poor prognosis. This nationwide retrospective study evaluated clinicopathological characteristics and prognostic factors among surgically resected patients in 2010. Among 14,999 individuals undergoing surgery, sarcomatoid carcinoma accounted for 1.4% and showed more advanced, aggressive pathology with worse overall and recurrence-free survival. Prognostic analysis identified larger tumor size, lymphatic permeation, and absence of adjuvant chemotherapy as unfavorable factors overall.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/surgically-resected-sarcomatoid-carcinoma-of-the-lung-a-nationwide-retrospective-study-in-2010/336549/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/surgically-resected-sarcomatoid-carcinoma-of-the-lung-a-nationwide-retrospective-study-in-2010/336549.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this nationwide retrospective study?","Question",{"text":112,"@type":113},"The study investigated clinicopathological characteristics and prognostic factors for surgically resected sarcomatoid carcinoma of the lung in 2010.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How common was sarcomatoid carcinoma among the surgical non-small cell lung cancer patients?",{"text":117,"@type":113},"Sarcomatoid carcinoma accounted for 1.4% of all patients who underwent surgical resection for non-small cell lung cancer in the 2010 cohort.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were associated with poorer overall and recurrence-free survival in the sarcomatoid carcinoma group?",{"text":121,"@type":113},"The multivariate analysis linked larger tumor size, lymphatic permeation, and no adjuvant chemotherapy with worse overall and recurrence-free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336549,1790016148,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Kaseda etal. BMC Cancer (2024) 24:938 [https://doi.org/10.1186/s12885-024-12728-2](https://doi.org/10.1186/s12885-024-12728-2)  \nBMC Cancer  \n RESEARCH Open Access  \nSurgically resected sarcomatoid carcinoma   of the lung: a nationwide retrospective study in 2010  \nKaoru Kaseda 1*, Keisuke Asakura1, Yasushi Shintani2, Jiro Okami3, Shinichi Toyooka4, Yukio Sato5,  \nShun-Ichi Watanabe6, Masayuki Chida7, Hidemi Suzuki8, Etsuo Miyaoka9, Ichiro Yoshino8, Hiroshi Date 10 and The Japanese Joint Committee of Lung Cancer Registry  \nAbstract  \nBackground Sarcomatoid carcinoma of the lung is a rare histological type of non-small cell lung cancer with a poor prognosis. We aimed to investigate the clinicopathological characteristics and prognostic factors of surgically resected sarcomatoid carcinoma of the lung.  \nMethods We retrospectively reviewed 14999 patients who underwent surgical resection for non-small cell lung cancer accumulated by the Japanese Joint Committee of Lung Cancer Registry in 2010. Clinicopathological characteristics and survival were compared between the sarcomatoid carcinoma and other non-small cell cancer groups. The prognostic factors in the sarcomatoid carcinoma group were identified using a multivariate Cox proportional hazard model.  \nResults Patients with sarcomatoid carcinoma comprised 1.4% of all patients. The sarcomatoid carcinoma group demonstrated a more aggressive pathology with presentation at more advanced stages, requiring more frequent extensive surgical resections. The sarcomatoid carcinoma group had remarkably poorer overall and recurrence-free survival than the other non-small cell lung cancer group. Adjuvant chemotherapy was associated with improved survival for pathological stage II–III sarcomatoid carcinoma cases rather than for pathological stage I disease. In the multivariate analysis, larger tumor size, lymphatic permeation, and no adjuvant chemotherapy were associated with the sarcomatoid carcinoma group’s overall and recurrence-free survival.  \nConclusions Surgically resected sarcomatoid carcinoma of the lung has a higher aggressive and metastatic potential and a worse prognosis than other non-small cell lung cancers. Adjuvant chemotherapy, which was associated with enhanced survival in patients with pathological stage II–III of the disease, could be considered for treating patients with pathological stage II–III sarcomatoid carcinoma of the lung.  \nKeywords Lung cancer, Adjuvant chemotherapy, Aggressive pathology, Prognosis, Survival  \n*Correspondence: Kaoru Kaseda[kaorukaseda@keio.jp](kaorukaseda@keio.jp)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nBackground  \nLung cancer is the main cause of cancer death in the world [1]. Sarcomatoid carcinoma of the lung is a rare histological type of non-small cell lung cancer (NSCLC) wit","cbCaitosISvaxU8j","https://ap.wps.com/l/cbCaitosISvaxU8j","pdf",1636739,14,"English","# Background\n## Lung cancer context and histological classification\n# Methods\n## Study design and patient cohort\n# Results\n## Proportion of sarcomatoid carcinoma and survival comparisons\n## Treatment association and multivariate prognostic factors\n# Conclusions\n## Clinical implications for adjuvant chemotherapy","[{\"question\":\"What is the main goal of this nationwide retrospective study?\",\"answer\":\"The study investigated clinicopathological characteristics and prognostic factors for surgically resected sarcomatoid carcinoma of the lung in 2010.\"},{\"question\":\"How common was sarcomatoid carcinoma among the surgical non-small cell lung cancer patients?\",\"answer\":\"Sarcomatoid carcinoma accounted for 1.4% of all patients who underwent surgical resection for non-small cell lung cancer in the 2010 cohort.\"},{\"question\":\"Which factors were associated with poorer overall and recurrence-free survival in the sarcomatoid carcinoma group?\",\"answer\":\"The multivariate analysis linked larger tumor size, lymphatic permeation, and no adjuvant chemotherapy with worse overall and recurrence-free survival.\"}]","Surgically resected sarcomatoid carcinoma of the lung - a nationwide retrospective study in 2010 | PDF",1790015578,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fa7bfcbbb3db6d110131724ba64385b7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a10107c4140d8a4ee169456d68ed6568.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43c820fe0400f29bee24c0d7232cae81.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30444c85c3e3e594a5e2f8043eed1178.webp",980,1301]